×

What's in Eli Lilly's Pharma Pipeline?

7:22 AM ET Wed, 25 July 2012

John Lechleiter, Eli Lilly chairman, president & CEO, breaks down his company's Q2 earnings, meeting revenue expectations of $5.6 billion. He also discusses several new drugs in phase three development.